331 related articles for article (PubMed ID: 17998446)
1. Sanfilippo syndrome type D: natural history and identification of 3 novel mutations in the GNS Gene.
Jansen AC; Cao H; Kaplan P; Silver K; Leonard G; De Meirleir L; Lissens W; Liebaers I; Veilleux M; Andermann F; Hegele RA; Andermann E
Arch Neurol; 2007 Nov; 64(11):1629-34. PubMed ID: 17998446
[TBL] [Abstract][Full Text] [Related]
2. A novel loss-of-function mutation in the GNS gene causes Sanfilippo syndrome type D.
Elçioglu NH; Pawlik B; Colak B; Beck M; Wollnik B
Genet Couns; 2009; 20(2):133-9. PubMed ID: 19650410
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the HGSNAT gene in Italian patients with mucopolysaccharidosis IIIC (Sanfilippo C syndrome). Mutation in brief #959. Online.
Fedele AO; Filocamo M; Di Rocco M; Sersale G; Lübke T; di Natale P; Cosma MP; Ballabio A
Hum Mutat; 2007 May; 28(5):523. PubMed ID: 17397050
[TBL] [Abstract][Full Text] [Related]
4. Mucopolysaccharidosis type IIID: 12 new patients and 15 novel mutations.
Valstar MJ; Bertoli-Avella AM; Wessels MW; Ruijter GJ; de Graaf B; Olmer R; Elfferich P; Neijs S; Kariminejad R; Suheyl Ezgü F; Tokatli A; Czartoryska B; Bosschaart AN; van den Bos-Terpstra F; Puissant H; Bürger F; Omran H; Eckert D; Filocamo M; Simeonov E; Willems PJ; Wevers RA; Niermeijer MF; Halley DJ; Poorthuis BJ; van Diggelen OP
Hum Mutat; 2010 May; 31(5):E1348-60. PubMed ID: 20232353
[TBL] [Abstract][Full Text] [Related]
5. Genomic basis of mucopolysaccharidosis type IIID (MIM 252940) revealed by sequencing of GNS encoding N-acetylglucosamine-6-sulfatase.
Mok A; Cao H; Hegele RA
Genomics; 2003 Jan; 81(1):1-5. PubMed ID: 12573255
[TBL] [Abstract][Full Text] [Related]
6. Mucopolysaccharidosis type IV: N-acetylgalactosamine-6-sulfatase mutations in Tunisian patients.
Laradi S; Tukel T; Khediri S; Shabbeer J; Erazo M; Chkioua L; Chaabouni M; Ferchichi S; Miled A; Desnick RJ
Mol Genet Metab; 2006 Mar; 87(3):213-8. PubMed ID: 16378744
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications.
Yogalingam G; Hopwood JJ
Hum Mutat; 2001 Oct; 18(4):264-81. PubMed ID: 11668611
[TBL] [Abstract][Full Text] [Related]
8. Sanfilippo syndrome type C: mutation spectrum in the heparan sulfate acetyl-CoA: alpha-glucosaminide N-acetyltransferase (HGSNAT) gene.
Feldhammer M; Durand S; Mrázová L; Boucher RM; Laframboise R; Steinfeld R; Wraith JE; Michelakakis H; van Diggelen OP; Hrebícek M; Kmoch S; Pshezhetsky AV
Hum Mutat; 2009 Jun; 30(6):918-25. PubMed ID: 19479962
[TBL] [Abstract][Full Text] [Related]
9. The mutation p.Ser298Pro in the sulphamidase gene (SGSH) is associated with a slowly progressive clinical phenotype in mucopolysaccharidosis type IIIA (Sanfilippo A syndrome).
Meyer A; Kossow K; Gal A; Steglich C; Mühlhausen C; Ullrich K; Braulke T; Muschol N
Hum Mutat; 2008 May; 29(5):770. PubMed ID: 18407553
[TBL] [Abstract][Full Text] [Related]
10. Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndrome.
Scott HS; Blanch L; Guo XH; Freeman C; Orsborn A; Baker E; Sutherland GR; Morris CP; Hopwood JJ
Nat Genet; 1995 Dec; 11(4):465-7. PubMed ID: 7493035
[TBL] [Abstract][Full Text] [Related]
11. [Postnatal and prenatal diagnosis of mucopolysaccharidosis type III (Sanfilippo syndrome)].
Zhang WM; Shi HP; Meng Y; Li BT; Qiu ZQ; Liu JT
Zhonghua Er Ke Za Zhi; 2008 Jun; 46(6):407-10. PubMed ID: 19099774
[TBL] [Abstract][Full Text] [Related]
12. Sanfilippo syndrome in Turkey: Identification of novel mutations in subtypes A and B.
Emre S; Terzioglu M; Tokatli A; Coskun T; Ozalp I; Weber B; Hopwood JJ
Hum Mutat; 2002 Feb; 19(2):184-5. PubMed ID: 11793481
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Sanfilippo phenotype severity from immunoquantification of heparan-N-sulfamidase in cultured fibroblasts from mucopolysaccharidosis type IIIA patients.
Perkins KJ; Muller V; Weber B; Hopwood JJ
Mol Genet Metab; 2001 Aug; 73(4):306-12. PubMed ID: 11509012
[TBL] [Abstract][Full Text] [Related]
14. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
[TBL] [Abstract][Full Text] [Related]
15. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
16. Human mucopolysaccharidosis IIID: clinical, biochemical, morphological and immunohistochemical characteristics.
Jones MZ; Alroy J; Rutledge JC; Taylor JW; Alvord EC; Toone J; Applegarth D; Hopwood JJ; Skutelsky E; Ianelli C; Thorley-Lawson D; Mitchell-Herpolsheimer C; Arias A; Sharp P; Evans W; Sillence D; Cavanagh KT
J Neuropathol Exp Neurol; 1997 Oct; 56(10):1158-67. PubMed ID: 9329460
[TBL] [Abstract][Full Text] [Related]
17. Sanfilippo type B syndrome (mucopolysaccharidosis III B): allelic heterogeneity corresponds to the wide spectrum of clinical phenotypes.
Weber B; Guo XH; Kleijer WJ; van de Kamp JJ; Poorthuis BJ; Hopwood JJ
Eur J Hum Genet; 1999 Jan; 7(1):34-44. PubMed ID: 10094189
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of 105 mucopolysaccharidosis type VI patients.
Karageorgos L; Brooks DA; Pollard A; Melville EL; Hein LK; Clements PR; Ketteridge D; Swiedler SJ; Beck M; Giugliani R; Harmatz P; Wraith JE; Guffon N; Leão Teles E; Sá Miranda MC; Hopwood JJ
Hum Mutat; 2007 Sep; 28(9):897-903. PubMed ID: 17458871
[TBL] [Abstract][Full Text] [Related]
19. Mucopolysaccharidosis type IIIB (Sanfilippo B): identification of 18 novel alpha-N-acetylglucosaminidase gene mutations.
Bunge S; Knigge A; Steglich C; Kleijer WJ; van Diggelen OP; Beck M; Gal A
J Med Genet; 1999 Jan; 36(1):28-31. PubMed ID: 9950362
[TBL] [Abstract][Full Text] [Related]
20. Enzyme Replacement Therapy for Mucopolysaccharidosis IIID using Recombinant Human α-
Wang F; Moen DR; Sauni C; Kan SH; Li S; Le SQ; Lomenick B; Zhang X; Ekins S; Singamsetty S; Wood J; Dickson PI; Chou TF
Mol Pharm; 2021 Jan; 18(1):214-227. PubMed ID: 33320673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
